These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A gene from the locus of enterocyte effacement that is required for enteropathogenic Escherichia coli to increase tight-junction permeability encodes a chaperone for EspF. Elliott SJ; O'Connell CB; Koutsouris A; Brinkley C; Donnenberg MS; Hecht G; Kaper JB Infect Immun; 2002 May; 70(5):2271-7. PubMed ID: 11953359 [TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Viswanathan VK; Koutsouris A; Lukic S; Pilkinton M; Simonovic I; Simonovic M; Hecht G Infect Immun; 2004 Jun; 72(6):3218-27. PubMed ID: 15155623 [TBL] [Abstract][Full Text] [Related]
9. Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions. Shaw RK; Cleary J; Murphy MS; Frankel G; Knutton S Infect Immun; 2005 Feb; 73(2):1243-51. PubMed ID: 15664974 [TBL] [Abstract][Full Text] [Related]
10. A novel proline-rich protein, EspF, is secreted from enteropathogenic Escherichia coli via the type III export pathway. McNamara BP; Donnenberg MS FEMS Microbiol Lett; 1998 Sep; 166(1):71-8. PubMed ID: 9741085 [TBL] [Abstract][Full Text] [Related]
11. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Nougayrède JP; Donnenberg MS Cell Microbiol; 2004 Nov; 6(11):1097-111. PubMed ID: 15469437 [TBL] [Abstract][Full Text] [Related]
13. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Dean P; Kenny B Mol Microbiol; 2004 Nov; 54(3):665-75. PubMed ID: 15491358 [TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 18 interacts with the enteropathogenic Escherichia coli secreted protein F (EspF) and is redistributed after infection. Viswanathan VK; Lukic S; Koutsouris A; Miao R; Muza MM; Hecht G Cell Microbiol; 2004 Oct; 6(10):987-97. PubMed ID: 15339273 [TBL] [Abstract][Full Text] [Related]
16. SepL, a protein required for enteropathogenic Escherichia coli type III translocation, interacts with secretion component SepD. O'Connell CB; Creasey EA; Knutton S; Elliott S; Crowther LJ; Luo W; Albert MJ; Kaper JB; Frankel G; Donnenberg MS Mol Microbiol; 2004 Jun; 52(6):1613-25. PubMed ID: 15186412 [TBL] [Abstract][Full Text] [Related]
17. Adhesion of enteropathogenic Escherichia coli to host cells. Nougayrède JP; Fernandes PJ; Donnenberg MS Cell Microbiol; 2003 Jun; 5(6):359-72. PubMed ID: 12780774 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of EPEC type III effector molecules. Kenny B Int J Med Microbiol; 2002 Feb; 291(6-7):469-77. PubMed ID: 11890546 [TBL] [Abstract][Full Text] [Related]
19. L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. Qin H; Zhang Z; Hang X; Jiang Y BMC Microbiol; 2009 Mar; 9():63. PubMed ID: 19331693 [TBL] [Abstract][Full Text] [Related]
20. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. Nagai T; Abe A; Sasakawa C J Biol Chem; 2005 Jan; 280(4):2998-3011. PubMed ID: 15533930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]